Become A Member

Pharmacovigilance begins from clinical phase and go on throughout the product life- cycle of the medicine.Pharmacovigilance focuses at assessment, detection and prevention of any possible medicine related problems and adverse event, particularly acute adverse event and long term adverse event of medicines, biotic products, herbalism and traditional drugs. In recent times, pharmacovigilance has evolved with amplifying significance to more clinical practice and public health knowledge. The chromatic techniques used in pharmacovigilance are active surveillance, passive surveillance, stimulated reporting, targeted clinical investigation, comparative observational studies, descriptive studies. In order to keep up the demands and preservation of case's health the new developments in pharmacovigilance is essential also, pharmacovigilance techniques can also be used to identify that which cases can develop ADRs and how they can develop ADR and for this the most important factor will be the use of the cases as a source of information in the field of pharmacovigilance.

Pharmacovigilance plays a critical part in assuring that cases enter safe medicines. Our knowledge of a medicine's adverse responses can be increased by chromatic means, including spontaneous reporting, intensive monitoring and database studies. New processes, both at a directorial and a scientific position, are being developed with the goal of strengthening pharmacovigilance. On a directorial position, these include tentative approval and threat management plans; on a scientific position, clarity and increased patient involvement are two important essentials. Ideal To review and talk over chromatic aspects of pharmacovigilance, including new methodological developments.

KEYWORDS: Pharmacovigilance, Active surveillance, Adverse events, Drug safety, Intensive monitoring, Spontaneous reporting.